M, F., I, M., A, M., G, F., M, B., R, M. S. L., . . . V, B. (2023). Anti-vascular endothelial growth factor monotherapy or combined with verteporfin photodynamic therapy for retinal angiomatous proliferation: A systematic review with meta-analysis. Frontiers in pharmacology, 14, 1141077. https://doi.org/10.3389/fphar.2023.1141077
Chicago Style (17th ed.) CitationM, Fallico, et al. "Anti-vascular Endothelial Growth Factor Monotherapy or Combined with Verteporfin Photodynamic Therapy for Retinal Angiomatous Proliferation: A Systematic Review with Meta-analysis." Frontiers in Pharmacology 14 (2023): 1141077. https://doi.org/10.3389/fphar.2023.1141077.
MLA (9th ed.) CitationM, Fallico, et al. "Anti-vascular Endothelial Growth Factor Monotherapy or Combined with Verteporfin Photodynamic Therapy for Retinal Angiomatous Proliferation: A Systematic Review with Meta-analysis." Frontiers in Pharmacology, vol. 14, 2023, p. 1141077, https://doi.org/10.3389/fphar.2023.1141077.